Literature DB >> 17291769

Clubbed thiazoles by MAOS: a novel approach to cyclin-dependent kinase 5/p25 inhibitors as a potential treatment for Alzheimer's disease.

Mahendra Ramesh Shiradkar1, Kalyan Chakravarthy Akula, Varaprasad Dasari, Vijayakumar Baru, Bhoomeshwar Chiningiri, Santosh Gandhi, Ranjit Kaur.   

Abstract

A novel clubbed triazolyl thiazole series of cdk5/p25 inhibitors, potentially useful for the treatment of Alzheimer's disease, is disclosed. Evaluation of the SAR of substitution within these series has allowed the identification of a range of compounds which significantly reduce brain cdk5/p25 and thus have potential as possible treatments for Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291769     DOI: 10.1016/j.bmc.2007.01.043

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Substituted dithiazole piperazine benzamides as novel amyloid beta peptide reducing agents.

Authors:  Hongjie Wang; Ruizhi Wang; Madepalli K Lakshmana; Adel Nefzi
Journal:  Bioorg Med Chem Lett       Date:  2014-08-13       Impact factor: 2.823

2.  Structure-activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors.

Authors:  Joydev K Laha; Xuemei Zhang; Lixin Qiao; Min Liu; Snigdha Chatterjee; Shaughnessy Robinson; Kenneth S Kosik; Gregory D Cuny
Journal:  Bioorg Med Chem Lett       Date:  2011-02-03       Impact factor: 2.823

3.  Discovery of thienoquinolone derivatives as selective and ATP non-competitive CDK5/p25 inhibitors by structure-based virtual screening.

Authors:  Arindam Chatterjee; Stephen J Cutler; Robert J Doerksen; Ikhlas A Khan; John S Williamson
Journal:  Bioorg Med Chem       Date:  2014-09-28       Impact factor: 3.641

4.  Molecular dynamic simulations give insight into the mechanism of binding between 2-aminothiazole inhibitors and CDK5.

Authors:  Wei Wang; Xiaoning Cao; Xiaolei Zhu; Yongliang Gu
Journal:  J Mol Model       Date:  2013-03-23       Impact factor: 1.810

5.  Synthesis and Biological Evaluation of Some Novel Thiazole-Based Heterocycles as Potential Anticancer and Antimicrobial Agents.

Authors:  Sraa Abu-Melha; Mastoura M Edrees; Heba H Salem; Nabila A Kheder; Sobhi M Gomha; Mohamad R Abdelaziz
Journal:  Molecules       Date:  2019-02-01       Impact factor: 4.411

6.  Sulfur-containing therapeutics in the treatment of Alzheimer's disease.

Authors:  Haizhou Zhu; Venkateshwara Dronamraju; Wei Xie; Swati S More
Journal:  Med Chem Res       Date:  2021-01-15       Impact factor: 1.965

7.  Stereoselective synthesis, X-ray analysis, computational studies and biological evaluation of new thiazole derivatives as potential anticancer agents.

Authors:  Yahia N Mabkhot; Mohammed M Alharbi; Salim S Al-Showiman; Hazem A Ghabbour; Nabila A Kheder; Saied M Soliman; Wolfgang Frey
Journal:  Chem Cent J       Date:  2018-05-11       Impact factor: 4.215

8.  Eco-Friendly Synthesis, Characterization and Biological Evaluation of Some Novel Pyrazolines Containing Thiazole Moiety as Potential Anticancer and Antimicrobial Agents.

Authors:  Mastoura M Edrees; Sraa Abu- Melha; Amirah M Saad; Nabila A Kheder; Sobhi M Gomha; Zeinab A Muhammad
Journal:  Molecules       Date:  2018-11-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.